Esteban Santos's most recent trade in AMGEN Inc. was a trade of 21,510 Nqso (Right to Buy) done . Disclosure was reported to the exchange on May 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 21,510 | 21,510 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 3,327 | 76,367 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.78 per share. | 02 May 2025 | 655 | 73,661 (0%) | 0% | 283.8 | 185,876 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.78 per share. | 02 May 2025 | 621 | 73,040 (0%) | 0% | 283.8 | 176,227 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.56 per share. | 30 Apr 2025 | 759 | 74,316 (0%) | 0% | 288.6 | 219,017 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.71 per share. | 17 Mar 2025 | 3,393 | 75,075 (0%) | 0% | 313.7 | 1,064,418 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,792 | 78,338 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 156.35 per share. | 19 Feb 2025 | 8,711 | 80,257 (0%) | 0% | 156.4 | 1,361,965 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 8,711 | 0 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Sale of securities on an exchange or to another person at price $ 292.84 per share. | 19 Feb 2025 | 8,711 | 71,546 (0%) | 0% | 292.8 | 2,550,903 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 19,469 | 38,938 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 300.30 per share. | 07 May 2024 | 2,997 | 71,304 (0%) | 0% | 300.3 | 899,999 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.29 per share. | 05 May 2024 | 617 | 68,307 (0%) | 0% | 311.3 | 192,066 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.37 per share. | 02 May 2024 | 606 | 68,924 (0%) | 0% | 277.4 | 168,086 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.38 per share. | 30 Apr 2024 | 683 | 69,530 (0%) | 0% | 276.4 | 188,768 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.87 per share. | 18 Mar 2024 | 6,137 | 70,213 (0%) | 0% | 268.9 | 1,650,055 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 12,278 | 76,125 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.89 per share. | 05 May 2023 | 579 | 63,582 (0%) | 0% | 231.9 | 134,264 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 30,100 | 30,100 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 3,559 | 64,877 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.97 per share. | 02 May 2023 | 716 | 64,161 (0%) | 0% | 236.0 | 168,955 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.74 per share. | 30 Apr 2023 | 660 | 61,318 (0%) | 0% | 239.7 | 158,228 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.57 per share. | 17 Mar 2023 | 3,881 | 61,978 (0%) | 0% | 234.6 | 910,366 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 7,753 | 65,676 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.10 per share. | 05 May 2022 | 589 | 57,661 (0%) | 0% | 236.1 | 139,063 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 29,695 | 29,695 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 3,637 | 58,958 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.92 per share. | 02 May 2022 | 708 | 58,250 (0%) | 0% | 230.9 | 163,491 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.87 per share. | 27 Apr 2022 | 599 | 55,321 (0%) | 0% | 249.9 | 149,672 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.86 per share. | 18 Mar 2022 | 4,370 | 55,920 (0%) | 0% | 235.9 | 1,030,708 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,740 | 60,119 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 34,420 | 34,420 | - | - | Nqso (Right to Buy) | |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 3,964 | 52,444 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. | 30 Apr 2021 | 685 | 51,108 (0%) | 0% | 239.6 | 164,153 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. | 30 Apr 2021 | 651 | 51,793 (0%) | 0% | 239.6 | 156,006 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.52 per share. | 27 Apr 2021 | 564 | 48,480 (0%) | 0% | 255.5 | 144,113 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.42 per share. | 19 Mar 2021 | 4,360 | 49,044 (0%) | 0% | 244.4 | 1,065,671 | Common Stock |
| Amgen | Esteban Santos | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 8,725 | 53,251 (0%) | 0% | 0 | Common Stock | |
| Amgen | Esteban Santos | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.67 per share. | 01 Aug 2020 | 2,165 | 44,376 (0%) | 0% | 244.7 | 529,711 | Common Stock |